Patient-centric strategies, novel biomarkers and digital medicine
Wednesday 3 October | Glass House, 450 Kendall Street, Cambridge, MA 02142
Across biopharma and healthcare industries, digital health technologies could be the key to unlocking better treatments, patient engagement, real world data collection and improved healthcare outcomes.
The big question is how?
Join us to hear from four industry experts at the forefront of digital health and neuroscience technology who will provide insights into:
- Digital trends and the changing clinical experience
- Disrupting pharmacotherapy with digital medicine
- Patient-centric trial designs and improving treatment efficacy
- Taking digital strategies from proof of concept to implementation
These talks will be followed by a panel discussion and open forum for a Q&A session.
The event is free to attend for invitees and includes canapés and refreshments.
Space is limited so register in advance to secure your seat.
We are pleased to have the following four prominent speakers from the worlds of drug development, digital health and patient engagement confirmed to speak at this event. Please scroll down the page to read their full bios.
- Corey Fowler, PhD – Associate Director, Global Clinical Development in CNS and Digital Medicine, Otsuka Pharmaceuticals
- Shwen Gwee, PhD – General Manager, Digital Accelerator, Novartis
- Sylvain Piquet – Chief Operating Officer, Peak Labs
- Jenny Barnett, PhD – Chief Scientific Officer, Cambridge Cognition
Why you should attend
If you work in the in the biopharmaceutical, health or MedTech industries or have a vested interest in digital health, this event will help you to become a digital leader.
- Discover emerging best-practices
- Hear from industry experts
- See the latest technologies
- Network with peers in the arena
- Future-proof your organization
Our industry is evolving. Don’t get left behind. Get your tickets here.
Who is this event for?
Professionals from biotech, pharmaceutical, CRO, healthcare and technology industries, and life science investors.
- Drug Development
- Medical Affairs
- Clinical Operations
- Clinical Innovation
- Patient Engagement
- Virtual Trials
- Digital Strategy
- Digital Biomarkers
Send any questions about the event or any that you have for our speakers to email@example.com
Space is limited so register today to avoid disappointment. Please also let us know if you can no longer attend so that we can offer your place to someone else.
About our speakers
Associate Director, Global Clinical Development in CNS and Digital Medicine
An experienced innovator specializing in digital medicines, Corey has experience in basic, translational, and clinical sciences with a doctorate degree in Pharmaceutical Sciences from the University of North Carolina.
Corey has worked in the clinical research industry for more than 10 years with experience in the concept and design, clinical operations, and ethics and regulatory oversight of clinical research studies for phases I-IV. He now focuses his time on designing and implementing digital medicine strategies at the forefront of pharmaceutical development.
Prior to joining Otsuka in 2016, Corey served in Clinical Scientist, Clinical Development, Program Management, Project Management, Business Development and Regulatory Affairs roles spanning industry and academia. Presently, he serves as Associate Director in Global Clinical Development in CNS and Digital Medicine at Otsuka Pharmaceuticals & Development Corporation.
General Manager, Digital Accelerator
A recognized pioneer in digital strategy and innovation within the biopharma industry, Shwen currently serves as General Manager of the Novartis Digital Accelerator program and was formerly Head of Digital Strategy for Global Clinical Operations at Biogen. Shwen drives innovative digital approaches to engage customers and enhance clinical trial recruitment and retention.
Shwen also sits on various advisory boards, including: Google (Healthcare), SXSW (Health), MM&M Healthcare Transformers, Doximity, and the Digital Health Coalition. Shwen is also very involved in the digital health start-up community and organizes start-up bootcamps, runs start-up pitch contests and plays an active role running healthcare hackathons around the world as part of the MIT Hacking Medicine team.
Chief Operating Officer
Sylvain is a seasoned international technology business leader, with a focus on operations, business development and digital marketing.
He has 15 years’ experience in digital advertising and now heads up the operations at Peak Labs, combining neuroscience and technology to achieve optimum user engagement.
Chief Scientific Officer
Named one of the 40 most influential Healthcare Technology Transformers in 2017, Jenny has led a number of innovative digital health projects in clinical trials and healthcare, helping to reshape the way technology is used to assess and monitor brain health.
Jenny has an MA in Experimental Psychology from Oxford University, a PhD in psychiatric epidemiology from the University of Cambridge, and has completed post-doctoral work at Massachusetts General Hospital and the Broad Institute of Harvard and MIT as well as being the author of over 50 academic publications.